chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient noted lip and tongue tingling around 3.5 hours after vaccination followed shortly after by swelling of her lower lip. She denies other symptoms at this time or later. She took diphenhydramine 50 mg that night around 8 pm and continued to take diphenhydramine 50 mg once daily at bedtime for the a total of 5 days. She noted that her lip remained swollen for approximately 2 days before resolving. She specifically denied other skin changes, trouble breathing or other concerns. Of note, she also reported feeling fatigued the day after the vaccine with the fatigue lasting for approximately 24-48 hours. She did not seek medical evaluation for this concern and the issue resolved without further treatment.
I received the Pizer Covid-19 Vaccine on February 23, 2021 and March 23, 2021.  Shortly thereafter, in April of 2021, I started experiencing fatigue, chest tightness, breathing issues and sleeplessness.  I thought these symptoms were indications of acid reflux and stress, and took Tylenol and over-the-counter acid reflux medication, Omeprazole.  On July 31, 2021, I went to Hospital due to shortness of breath and chest pain.  I was then transferred to another hospital, where they ran blood work and tests.  I stayed in the hospital until August 3, 2021 and was told that I had inflammation around my heart.  Later, I followed-up with Dr., a Cardiologist, on August 18, 2021 and was told that I had in fact, suffered a Heart Attack!    Hence, I have been on seven (7) different medications (Omeprazole 20 mg, Aspirin 81 mg, Colchicine 0.6 mg, Isosorbide Mononitrate 30 mg, Atorvastatin 80 mg, Lisinopril 2.5 mg, and Metoprolol ER Succinate 25 mg) for my conditions in order for the inflammation to subside and have a stent placed in a blocked artery.  On September 27, 2021, I was informed by Dr. that a stent would be too risky to perform, since the artery is blocked 100%.  Therefore, I will have to live with this "permanent injury" for the rest of my life.  Consequently, I have been told I have a rare case of inflammation.  Therefore, I certainly believe it is Covid-19 vaccine related, and have filed a VAERS report (Vaccine Adverse Event Reporting System) with the CDC.  Thus, I do not have a family history of Heart Disease and never have been on ANY prescription medications other than for very brief illnesses.    These are some of the symptoms and/or side effects that I have experienced from my medications, since August 5, 2021 to date:    1.)    Sore throat/cold 2.)    Headaches/migraines 3.)    Diarrhea 4.)    Chills/hot and cold 5.)    Stomach aches 6.)    Light-headedness 7.)    Low energy 8.)    Unstable on feet; fell on September 15, 2021 around 12:30 p.m. 9.)    Sleeplessness  10.)  Loss of appetite 11.)  Tightness in left calf area 12.)  Cramping in both legs 13.)  Fever 14,)  Feeling depressed 15.)  Woozy and dizzy 16.)  Constipation 17.)  Excessive coughing 18.)  Body aches, specifically, back, arms and legs 19.)  Nausea
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 27-SEP-2012, the patient was inoculated with ZOSTAVAX at the department of health as recommended for routine adult health maintenance and for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. In 2014, the patient was treated by a physician for a persistent and severe vesicular rash, which was diagnosed as herpes zoster. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages.  The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
The next morning after I had arm pain and was very fatigued which lasted about a week.  On 2/27  I started experiencing on and off vaginal bleeding but drs had no treatment they could provide.  I was diagnosed with a threathened miscarrage and on 3/22/2021 I miscarried.  EDD-11/7/2021. There were several bouts of bloodwork perfomed which were normal until the miscarrage occurred and all ultrasounds were normal until the 3rd which showed the miscarriage.
Patient received 2nd COVID vaccine at 1055. At 1057 pt complained of dizziness and palpitations. LPN and Medical Assistant took a set of vitals and determined elevated HR and BP. Called EM Coordinator. Medical Assistant and EM coordinator transported patient in wheelchair to ER for further evaluation.
24 Hours after injection- High fever (103), lethargy, shortness of breath/quick breathing
This spontaneous report as received from a nurse and the doctor's office refers to a patient of unknown age. The patient was subcutaneously vaccinated with 0.65 ml ZOSTAVAX (Lot# reported as 0468AE, Exp date : April 2013). No other co-suspects were reported. No concomitant medications were reported. It was reported that the patient received ZOSTAVAX and had "heated, raised swelling with redness in the entire upper arm" on an unknown date. The patient had sought unspecified medical attention. No treatment information was reported. The outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
lymph glands under left arm were quite swollen and sore; fever; chills; sore arm at the injection site; Felt tired and crappy; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 03Apr2021 at 09:30 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient did not have an allergy to any medications, food, or other products. Concomitant medications were unspecified and received within two weeks of the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Mar2021 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not experience any side effect with the first dose. On 04Apr2021 at 06:30, the patient woke up with fever, chills, and sore arm at the injection site and felt tired and crappy, then felt better around midnight. On 05Apr2021, when the patient woke up, the patient reported that the lymph glands under the left arm were quite swollen and sore on the same vaccinated arm and lasted for 3 days. On 08Apr2021, the patient was all fine on day 4. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with acetaminophen 500mg (MANUFACTURER UNKNOWN) on 04Apr2021; 1 tablet taken and the fever went away for a while, repeated as needed and unknown if still ongoing. The clinical outcome of the events fever, chills, sore arm at the injection site, felt tired and crappy, lymph glands under the left arm were quite swollen and sore, were recovered on 08Apr2021.  No follow-up attempts are needed. No further information is expected.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Feeling faint, on the verge of fainting-Mild, Systemic: Flushed / Sweating-Mild
Employee gave her daughter in law covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Employee gave her daughter in law covid) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Employee gave her daughter in law covid). At the time of the report, COVID-19 (Employee gave her daughter in law covid) outcome was unknown.            Reporter states that the patient was vaccinated and had both vaccinations but does not know which vaccines he had. The caller also verified that the patient was asymptomatic.  No concomitant medications were reported  No treatment information was provided  Company Comment-This case concerns a male patient of unknown age, with no medical history reported, who experienced the unexpected non-serious adverse event of special interest of COVID-19. The event occurred after the first dose of COVID-19 vaccine, suspected to be Moderna vaccine but brand was not specified by the reporter. Exact vaccination and event dates were not provided. The rechallenge was not applicable since the events occurred after the second dose. The benefit-risk relationship of Moderna COVID-19 vaccine is not affected by this report. More information is requested for confirmation of vaccine brand, vaccination and event date.; Sender's Comments: This case concerns a male patient of unknown age, with no medical history reported, who experienced the unexpected non-serious adverse event of special interest of COVID-19. The event occurred after the first dose of COVID-19 vaccine, suspected to be Moderna vaccine but brand was not specified by the reporter. Exact vaccination and event dates were not provided. The rechallenge was not applicable since the events occurred after the second dose. The benefit-risk relationship of Moderna COVID-19 vaccine is not affected by this report. More information is requested for confirmation of vaccine brand, vaccination and event date.
Pt began with hives at elbows then at belt line then gradually on 10/20/09 moved to hips. Took BENADRYL at hs, resolved hives at belt line. Next night bra line itchy and thighs, right eye puffy on 10/26/09. Continues with intermittent hives. Prescribed tapering dose of prednisone. Currently on prednisone. No hives noted at this time.
Two-three hours after vaccines given on 7-1-10. Mom noted redness and swelling of (R) thigh. The site of DTaP was seen for office visit 7-6-10 redness and swelling had subsided. Entire front of thigh slightly pink with minimal induration.
Information has been received from a  69 year old female consumer with penicillin allergy, allergic reaction to cefaclor, erythromycin and progesterone, who was vaccinated with a dose of Pneumovax 23. Concomitant therapy included penicillin (unspecified), Ceclor, erythromycin and Prometrium. Unspecified medical attention was sought. The outcome was unknown. Additional information has been requested. This is in follow-up to report (s) previously submitted on 7/30/2007. Initial and follow up information has been received from a 69 year old female patient with allergies to CECLOR, erythromycin, PROMETRIUM, aspirin, and INDERAL, who on 16-JUN-2000 was vaccinated intramuscularly in the right deltoid with a first dose of PNEUMOVAX  vaccine (Lot# "466785"). Subsequently the patient had an allergic reaction to PNEUMOVAX vaccine. The injection site was red, swollen, sore and hard. The patient also developed red blotches and experienced soreness under the arm. The patient was advised not to have another shot of PNEUMOVAX vaccine. The outcome was unknown. Additional information is not expected.
CHILLS; FEVER; NAUSEA; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 2021 for prophylactic vaccination. The company was unable to perform follow up to request batch number.  No concomitant medications were reported. On 2021, the subject experienced chills. On 2021, the subject experienced fever. On 2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chills and nausea was not reported. This report was non-serious.
hives and itchiness hands and torso, no respiratory distress.  Treated with benadryl and improved.  Had a hive on hand and torso following day
Left arm 5cm area of erythema. VIW after arm of VARIVAX.
Patient contracted COVID after being fully vaccinated Runny nose, congestion, sore throat, fatigue
Skin is on fire, chills, headache, exhaustion, hurts to walk.  All began 16 hours after shot and has continued in intensity throughout the day
patient received dose from expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received dose from expired vaccine) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050E21A and 062E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received dose from expired vaccine). On 21-Oct-2021, EXPIRED PRODUCT ADMINISTERED (patient received dose from expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD-2021-360687 (Patient Link).
Five days after the vaccination I started listening to a buzzing in my right ear. I learned that this is called Tinnitus and that more people have found to have tinnitus or that their tinnitus has increased after vaccination. One week after, I am not sure if the Tinnitus is getting better or I am getting used to it. Next week I'll see my doctor.
Right ankle swelling upward to knee; diagnosed with blood clot per patient; treated with Eliquis.
SEVERE LEG PAIN; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform  follow up to request batch number/Lot number. No concomitant medications were reported. On an unspecified date, the subject experienced severe leg pain. Laboratory data (dates unspecified) included: Sonogram (NR: not provided) Negative. Treatment medications (dates unspecified) included: acetylsalicylic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of severe leg pain was not reported. This report was non-serious.
sore arm; nausea; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm), NAUSEA (nausea) and DIZZINESS (dizziness) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced MYALGIA (sore arm), NAUSEA (nausea) and DIZZINESS (dizziness). At the time of the report, MYALGIA (sore arm), NAUSEA (nausea) and DIZZINESS (dizziness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
product was stored outside extended stability data and then administered.; This case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix) for prophylaxis.   On an unknown date, the patient received Havrix. On an unknown date, unknown after receiving Havrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   The reporter considered the incorrect storage of drug to be related to Havrix.     Additional Information: GSK receipt date: 06-September-2022: Reporters comment:  The reporter reported that patient was inadvertently administered Havrix following a temperature excursion. Nurse stated this was already reported by another HCP and does not have any details regarding this. The reporter reported would send other HCP contact information in follow up email. Nurse only wanted information on when to revaccinate. Confirmed with registered nurse that product was stored outside extended stability data and then administered. The reporter also mentioned Havrix was outside of recommended range for 3 months and administered to patient. No further details provided. Additional Supportive information: The product was stored outside extended stability data and then administered to patient, which led to incorrect storage of drug.
intermittent tingling above and below right ear, occurs several times daily, lasting about 1 minute. No burning, pain, numbness, changes in vision or hearing.
48 hours after vaccination 2/4/21, diarrhea, followed by extreme, dizziness/lightheadedness, all day., starting 9:30am,2/6/21 Lightheadedness ongoing( day of reporting)2/7/21
On 17May2021, he started having heart palpitations; Palpitations was reported as worsened; This is a spontaneous report from a contactable consumer (patient). A 32-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6208), dose 2 via an unspecified route of administration, administered in Arm Right on 13Mar2021 09:00 (at the age of 32-year-old) as dose 2, single for COVID-19 immunization. Medical history included, HIV positive (diagnosed 3 years ago, his viral load is currently undetectable due to being on medications) from an unknown date and unknown if ongoing and congestive heart failure (His great-grandmother had congestive heart failure at the age of 95, but she lived to be 100), family history from an unknown date and unknown if ongoing. Concomitant medication(s) included dolutegravir sodium, lamivudine (DOVATO, tablet) taken for HIV from an unspecified start date and ongoing (Started this about 2 years ago). The patient previously received first dose of BNT162B2 (Lot number: EN6203), via an unspecified route of administration, administered in Right arm on 20Feb2021 (at the age of 32-year-old) for COVID-19 Immunization. Vaccine was not administered at Military Facility. Patient did not receive additional vaccines administered on same date of the Pfizer suspect. Prior vaccinations (within 4 weeks) was none reported. Prior vaccinations, patient did not have adverse event. He started having heart palpitations on 17May2021 13:00, (24-hour clock): at 1:00 pm that afternoon after lunch, palpitations was reported as worsened on May2021. Patient again stated that he was started to develop heart palpitations; could the vaccine be linked to it. The palpitations started about 3 weeks ago, and he went to the ER the first time it happened because it scared him. They ran some tests, but all the test results were normal, but he still had the palpitations. He went to the ER on 17May2021, which was the day the palpitations started, and was told to follow up with a cardiologist. He went to a Cardiologist the next day, who had him wear a heart monitor for 7 days. Stated that he sent the heart monitor back in and was still waiting for the results. Stated that he was starting to get the palpitations more. Patient visited emergency room on 17May2021 and physician office (went to a cardiologist the next day, heart monitor for 7 days, sent it back and was still waiting for the results) for adverse events. He was not admitted to the hospital. The patient underwent lab tests and procedures which included Blood Work: his viral load is still undetectable and Echo on heart: no blood clots or abnormality on 17May2021, Heart monitor: still waiting for the results on 18May2021, checked for staph infection: unknown results and thyroid: normal on 17May2021. Test was done while in ER on 17May2021. There was investigation assessment. The outcome of event on 17May2021, he started having heart palpitations was not recovered and unknown for another event.  Follow-up attempts are completed. No further information is expected.
Itchy sensation at site on (L) posterior upper arm. Site approximately 4 cm long x 3 cm wide. Itchy sensation began 12-20-16. Denies any systemic reactions. Nurse placed BAND-AID over site. Advised pt. to take BENADRYL for itchy sensation. Keep area covered until reaction subsides.
1 hr p/immun pt has asthma attack; required use of inhaler; that evening pt had fever & sore throat;
1:08  Injection;  30 min wait time ,   1:40 Tingly lower lip and dizzy  1:45 Benadryl 50mg; bp 122/72  HR 83, pox 99 2pm still dizzy ", somewhat ; somewhat less tingly lip" couldn't give a scale 2:20  per DNS Deb, improved slightly. 2:30 very tired - may be contributed to 50mg Benadryl. 2:30 medical director examined.   She feels okay, sent home with another staff member.  Suggest contact her dr tomorrow and  before next vaccine.  Suggest do it at a medical facility.
Fever of 104.0 experienced convuls, mom said pt had sl cold when shot was given; 7 day F/U 11APR91;
Pt had ZOSTAVAX on the 5th. Site started to itch Friday then became a shingles  spot approximately 3 x 3 inches around site Sat. Site improved some Sun was still red in center.
pt recv vax 26JUN95 & on 6AUG97 pt devel chickenpox;pt recovered from chickenpox;
Information has been received from a physician, for ZOSTAVAX (Merck), a Pregnancy Registry product, concerning a 34 year old female study participant in a clinical study with no medical history and no drug reactions/allergies who on 23-AUG-2011 was subcutaneously vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 669746/0356AA, exp:09-JUN-2012). Concomitant therapy included OXY ELITE PRO, GNC WOMENS ULTRA MEGA ACTIVE and TONALIN CLA. The reporter stated that the patient participated in a non Merck clinical study received ZOSTAVAX (Merck) and was pregnant. The patient was given a urine pregnancy test on 23-AUG-2011 before ZOSTAVAX (Merck) vaccination and it was negative. The patient was told not to be pregnant at least 3 months after vaccination with ZOSTAVAX (Merck). The patient did a urine pregnancy test at home on 26-JAN-2012 that was positive but the patient did not follow up with an obstetrician until the end of March, 2012. An unspecified obstetrician did an ultrasound end of March, 2012 an estimated LMP was 23-DEC-2011 and due date was 28-SEP-2012. Physician reported patient did have 2 children, had a 'VZV serology that was positive which was an inclusion criteria for the study" and having a "pregnancy that qualifies as normal". Additional information has been requested. Update (10-OCT-2012): follow-up information received from the reporting physician. The physician informed that the patient delivered a healthy baby girl on 28-SEP-2012 and left the hospital about 48 hours later. No additional information was provided.